BDNF and arthritic joint disease: The knowledge of neurotrophin expression on cells from the inflamed synovial compartment in arthritis patients adds to the potential evaluation of pathogenic mechanisms and the development of new therapeutic strategies (e.g. the pharmacological blockade of the NGF receptor and their signaling pathway by using receptor antagonists).